搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
3 小时
Exelixis股价创52周新高,达27.88美元,增长强劲
Exelixis Inc.
23 小时
Truist维持Exelixis买入评级,目标价33美元,受默沙东集团交易影响
周一,Truist Securities维持对Exelixis(NASDAQ:EXEL)的买入评级,目标价为33.00美元。这是在Exelixis与默沙东集团(NYSE:MRK)最近宣布合作进行某些类型癌症治疗的临床试验之后。两家公司将合作评估Exelixis的酪氨酸激酶抑制剂zanzalintinib与默沙东集团的抗PD-1疗法KEYTRUDA的组合,在一项针对头颈部鳞状细胞癌(HNSCC)患者 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
To close 1,200 US stores
IDF finds Hezbollah bunker
IP theft in NASCAR
Inter-Korean roads blown up
Town hall interrupted
BCBS settles antitrust claims
AR casino challenge ruling
2,471-pound pumpkin wins
Jacket to be auctioned
MA town fines resident
Rare comet spotted
Detroit off-duty officer killed
COVID linked to diabetes?
Arrests at the NYSE
Tech founder's murder trial
GA must certify election
Settles gamers' antitrust suit
ISR strikes Lebanon town
US troops arrive In Israel
Signs gas price spikes law
Rapper Ka dies at 52
Sued by workers for injuries
Medicare open enrollment
Files for bankruptcy
New reptile fossil found
Signals caution on rate cuts
Arrested for FEMA threats
Sign nuclear power deal
Meat items recall expands
反馈